Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02512276 · ClinicalTrials.gov registry record · NA
Tele-Pharmacy Intervention to Improve Treatment Adherence
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 4,078
- Enrollment target
NCT02512276: Completed NA study, sponsored by Brigham and Women's Hospital.
NCT02512276 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 4,078 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (190% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02512276, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,078 participants
- Enrollment target
Study Summary
The purpose of this cluster randomized controlled trial is to evaluate whether a novel tele-pharmacist-based intervention for patients with hyperlipidemia, hypertension, and diabetes improves medication adherence, disease control, and patients' understanding of their treatment.
Primary Outcome
Average proportion of days covered (PDC) for medications to treat eligible conditions. An eligible condition is a diagnosis of either hyperlipidemia, hypertension, or diabetes and evidence of poor control for that condition at the time of enrollment. Adherence will be measured as an average of averages PDC only for medications that qualified a patient for inclusion in the study. Medication adherence is often reported as percentage of days covered.
Interventions
- BEHAVIORAL Telepharmacist intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,078 participants |
| Start Date | 2015-08 |
| Est. Completion | 2017-10 |
| Phase | NA |
What the finished NCT02512276 record still lists
NCT02512276 is an interventional study that assigns participants to a tested intervention. Its 4,078 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (190% higher).
The record links to 0 conditions, and to 1 intervention - of which Telepharmacist intervention is the first listed.
NCT02512276 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02512276 about?
NCT02512276 is a clinical study titled "Tele-Pharmacy Intervention to Improve Treatment Adherence". The purpose of this cluster randomized controlled trial is to evaluate whether a novel tele-pharmacist-based intervention for patients with hyperlipidemia, hypertension, and diabetes improves medication adherence, disease control, and patients' understanding of their treatment.
What is the current status of trial NCT02512276?
This trial is currently completed. It is a NA study. The enrollment target is 4,078 participants. The study started on 2015-08. Estimated completion is 2017-10.
What interventions are being tested in trial NCT02512276?
The interventions under investigation include: Telepharmacist intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02512276?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02512276's enrollment target sits among peer trials
4,078 32nd of 2000 higher than 1,969 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03388606 · 4,100 participants
Characterization and Treatment of Adolescent Depression
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
- NCT00897117 · 4,000 participants
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia